Target intelligence / Profile preview

FK506-binding protein F36V mutant domain (F36V-FKBP12)

Target
F36V-FKBP12
Molecular classification
Peptidyl-prolyl cis-trans isomerase, Enzyme, Mutant protein
01

Overview

The FK506-binding protein (FKBP) F36V mutant is a genetically engineered variant of the human FKBP12 protein, in which the phenylalanine at position 36 is replaced by valine. This mutation creates a unique, hydrophobic specificity pocket within the ligand-binding site of FKBP12, enabling selective binding to synthetic ligands that do not interact with wild-type FKBP12. It is widely used in chemical biology as part of dimerization systems. Synthetic ligands can induce or disrupt dimerization/fusion events involving proteins tagged with this mutant domain, enabling conditional control over signaling pathways or transcriptional activity. Ligand-induced recruitment of E3 ubiquitin ligases via fusion to an F36V-FKBP tag enables rapid degradation of target proteins.

Other names
FKBP12 F36V mutantF36V FKBPFKBP F36VFKBP12-F36V
02

Mechanism of action

Selective binding to synthetic ligands with "bumped" substituents, enabling conditional protein dimerization or degradation.

03

Biological functions

Protein foldingCellular signalingChemical inducer of dimerizationTargeted protein degradation
04

Safety considerations

Potential off-target effects if ligand specificity is not strictly maintained.Immunogenicity of the protein in vivo.
05

Interacting drugs

AP21967

2 more in the full profile.

Beyond the preview

Go deeper on FK506-binding protein F36V mutant domain (F36V-FKBP12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FK506-binding protein F36V mutant domain (F36V-FKBP12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call